Uncontrolled Moderate to Severe Asthma? Help Test A Potential New Treatment!

Please note: This trial has finished recruiting and is not accepting new participants.

Research Centre: TrialsWest
Location: 6 Barrington Street, Spearwood, WA, 6163
Research Centre: Respiratory Clinical Trials
Location: 83 Fullarton Rd, Kent Town SA, Australia
Lead Doctors: Professor Peter Bremner; Dr. Michael Chia
Ethics Committee: This study has been reviewed and approved by Bellberry HREC Human Research Ethics Committee


Asthma is a condition that makes breathing difficult due to airways narrowing due to inflammation and swelling. For most asthma patients, their treatment is successful and can provide long-term control. However, 10- 15% of asthmatics still show symptoms despite using maximum recommended treatments. 

This study seeks to investigate the potential benefits of a potential new treatment (Itolizumab) to help manage uncontrolled moderate-to-severe asthma.

The study seeks adults aged 18 to 75 years old who are diagnosed with moderate-to-severe asthma and are currently using asthma medication. Participants must attend a minimum of 9 study site visits at the research site over approximately 12 weeks.

Why Participate? 

  • You will be seen by a specialist to help with your asthma condition.
  • You will receive an optimal treatment plan to help manage your asthma after your participation in the study is completed.
  • You may prevent further asthma complications.
  • You will receive a payment of $150 to cover travel, parking, meals and other expenses whilst participating in this study.
  • You will be helping to advance medical research.

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
  • Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
  • Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

  • Adults aged 18-75 years old diagnosed with uncontrolled moderate-to-severe asthma.
  • Must have been taking medication for their asthma for at least 3 months.
  • Must have experienced a significant asthma exacerbation within the past 12 months.
  • Able to attend a minimum of 9 study visits at the research site over approximately 12 weeks.

What Next?

  1. Click the link below to enter your contact details and answer some eligibility questions.
  2. The research centre will then contact you by phone to discuss the trial and answer your questions.
Click Here to Enter Your Contact Details and Be Contacted by Phone About the Trial